| abstract |
The invention relates to a pharmaceutical composition adapted for administration to the lungs by inhalation, which includes glitazone, for example pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and / or excipients, the glitazone contained in the composition comprising at least 95% by weight enantiomer 5R and less than 5% of the enantiomer 5S. In addition, a description of the use of the composition and its set. |